-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Orchard Therapeutics plc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2018 to Q3 2023.
- Orchard Therapeutics plc Operating Income (Loss) for the quarter ending September 30, 2023 was -$21.6M, a 15.2% increase year-over-year.
- Orchard Therapeutics plc Operating Income (Loss) for the twelve months ending September 30, 2023 was -$102M, a 22.7% increase year-over-year.
- Orchard Therapeutics plc annual Operating Income (Loss) for 2022 was -$127M, a 9.5% increase from 2021.
- Orchard Therapeutics plc annual Operating Income (Loss) for 2021 was -$140M, a 10.5% increase from 2020.
- Orchard Therapeutics plc annual Operating Income (Loss) for 2020 was -$157M, a 9.2% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)